Cremer, S., Pilgram, L., Berkowitsch, A., Stecher, M., Rieg, S., Shumliakivska, M., . . . group, L. s. (2021). Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. Public Library of Science (PLoS).
Style de citation Chicago (17e éd.)Cremer, Sebastian, et al. Angiotensin II Receptor Blocker Intake Associates with Reduced Markers of Inflammatory Activation and Decreased Mortality in Patients with Cardiovascular Comorbidities and COVID-19 Disease. Public Library of Science (PLoS), 2021.
Style de citation MLA (8e éd.)Cremer, Sebastian, et al. Angiotensin II Receptor Blocker Intake Associates with Reduced Markers of Inflammatory Activation and Decreased Mortality in Patients with Cardiovascular Comorbidities and COVID-19 Disease. Public Library of Science (PLoS), 2021.